Skip to main content
. 2021 Jan 22;21:33. doi: 10.1186/s12876-021-01604-z

Table 2.

Efficacy of vedolizumab

Patients with clinical remission (%) Patients with corticosteroid-free remission (%) Patients with endoscopic remission (%)
Week 17 ± 0.5 1 year Week 17 ± 0.5 1 year Month 8.9 ± 0.7
UC 38/106 (36) 40/56 (71) 31/106 (29) 38/56 (68) 29/64 (45)
CD 26/75 (35) 16/25 (64) 22/75 (29) 14/25 (56)